Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cancer immunotherapy: the beginning of the end of cancer?
Farkona S, Diamandis EP, Blasutig IM. Farkona S, et al. BMC Med. 2016 May 5;14:73. doi: 10.1186/s12916-016-0623-5. BMC Med. 2016. PMID: 27151159 Free PMC article. Review.
The Phoenix Rises: The Rebirth of Cancer Immunotherapy.
Blasutig IM, Farkona S, Buchbinder EI, Luke JJ, Sharma P, Sznol M. Blasutig IM, et al. Among authors: farkona s. Clin Chem. 2017 Jul;63(7):1190-1195. doi: 10.1373/clinchem.2016.267849. Epub 2017 May 17. Clin Chem. 2017. PMID: 28515097 No abstract available.
False biomarker discovery due to reactivity of a commercial ELISA for CUZD1 with cancer antigen CA125.
Prassas I, Brinc D, Farkona S, Leung F, Dimitromanolakis A, Chrystoja CC, Brand R, Kulasingam V, Blasutig IM, Diamandis EP. Prassas I, et al. Among authors: farkona s. Clin Chem. 2014 Feb;60(2):381-8. doi: 10.1373/clinchem.2013.215236. Epub 2013 Oct 4. Clin Chem. 2014. PMID: 24097894
Generation of monoclonal antibodies and development of an immunofluorometric assay for the detection of CUZD1 in tissues and biological fluids.
Farkona S, Soosaipillai A, Filippou P, Korbakis D, Serra S, Rückert F, Diamandis EP, Blasutig IM. Farkona S, et al. Clin Biochem. 2017 Dec;50(18):1168-1174. doi: 10.1016/j.clinbiochem.2017.07.012. Epub 2017 Jul 23. Clin Biochem. 2017. PMID: 28746862
Biochemical and functional characterization of the human tissue kallikrein 9.
Filippou PS, Farkona S, Brinc D, Yu Y, Prassas I, Diamandis EP. Filippou PS, et al. Among authors: farkona s. Biochem J. 2017 Jul 6;474(14):2417-2433. doi: 10.1042/BCJ20170174. Biochem J. 2017. PMID: 28559305
Novel immunoassays for detection of CUZD1 autoantibodies in serum of patients with inflammatory bowel diseases.
Farkona S, Soosaipillai A, Filippou P, Liaskos C, Bogdanos DP, Diamandis EP, Blasutig IM. Farkona S, et al. Clin Chem Lab Med. 2017 Aug 28;55(10):1574-1581. doi: 10.1515/cclm-2016-1120. Clin Chem Lab Med. 2017. PMID: 28343172
A new enzyme-linked immunosorbent assay (ELISA) for human free and bound kallikrein 9.
Filippou P, Korbakis D, Farkona S, Soosaipillai A, Karakosta T, Diamandis EP. Filippou P, et al. Among authors: farkona s. Clin Proteomics. 2017 Jan 17;14:4. doi: 10.1186/s12014-017-9140-6. eCollection 2017. Clin Proteomics. 2017. PMID: 28115917 Free PMC article.
PIK3CA mutational status in circulating tumor cells can change during disease recurrence or progression in patients with breast cancer.
Markou A, Farkona S, Schiza C, Efstathiou T, Kounelis S, Malamos N, Georgoulias V, Lianidou E. Markou A, et al. Among authors: farkona s. Clin Cancer Res. 2014 Nov 15;20(22):5823-34. doi: 10.1158/1078-0432.CCR-14-0149. Clin Cancer Res. 2014. PMID: 25398847 Free article.
Extracellular Matrix Injury of Kidney Allografts in Antibody-Mediated Rejection: A Proteomics Study.
Clotet-Freixas S, McEvoy CM, Batruch I, Pastrello C, Kotlyar M, Van JAD, Arambewela M, Boshart A, Farkona S, Niu Y, Li Y, Famure O, Bozovic A, Kulasingam V, Chen P, Kim SJ, Chan E, Moshkelgosha S, Rahman SA, Das J, Martinu T, Juvet S, Jurisica I, Chruscinski A, John R, Konvalinka A. Clotet-Freixas S, et al. Among authors: farkona s. J Am Soc Nephrol. 2020 Sep 8:ASN.2020030286. doi: 10.1681/ASN.2020030286. Online ahead of print. J Am Soc Nephrol. 2020. PMID: 32900843